找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cholestatic Liver Disease; Keith D. Lindor,Jayant A. Talwalkar Book 20081st edition Humana Press 2008 autoimmune hepatitis.biopsy.liver tr

[復制鏈接]
樓主: Exacting
11#
發(fā)表于 2025-3-23 13:08:43 | 只看該作者
12#
發(fā)表于 2025-3-23 15:51:01 | 只看該作者
Rechner-Einsatz in der Wasserkraftwirtschaft. Conditions will be discussed in terms of the likely anatomic level of involvement e.g. at the level of the canaliculus, the intralobular ductules, and large intrahepatic bile ducts, emphasizing and highlighting common aspects of the pathophysiology of several of these processes.
13#
發(fā)表于 2025-3-23 20:50:07 | 只看該作者
Rare Causes of Cholestasis, cholestasis, benign recurrent intrahepatic cholestasis, and Aagenaes syndrome to name a few. Further characterization of these rare cholestatic disorders and the defective genes associated with them will aid in understanding hepatobiliary biology and other more common causes of intrahepatic cholestasis.
14#
發(fā)表于 2025-3-24 02:01:31 | 只看該作者
15#
發(fā)表于 2025-3-24 06:22:45 | 只看該作者
16#
發(fā)表于 2025-3-24 10:12:07 | 只看該作者
Drug-Induced Cholestasis,ced by medications and herbal supplements and the mechanisms of cholestasis caused by medications. We also provide some insights into treatment. In addition, specific examples of medications and herbal supplements that are known to cause one of the cholestatic syndromes are provided.
17#
發(fā)表于 2025-3-24 12:11:11 | 只看該作者
Primary Biliary Cirrhosis,pensated liver disease may eventually develop. Ursodeoxycholic acid is the only recommended treatment and may improve survival in selected patients. Prognostic models help predict natural history of the disease. Liver transplantation is the only definitive therapy once end-stage liver disease occurs.
18#
發(fā)表于 2025-3-24 15:43:41 | 只看該作者
Complications of Cholestasis,holangitis (PSC), which is then extrapolated to patients with other cholestatic diseases. This section will review the pathophysiology and management of osteoporosis, pruritus, dyslipidemia, and vitamin deficiencies.
19#
發(fā)表于 2025-3-24 21:14:48 | 只看該作者
20#
發(fā)表于 2025-3-25 02:07:48 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 09:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
绥棱县| 揭西县| 菏泽市| 来安县| 曲阳县| 郸城县| 陕西省| 万全县| 崇信县| 富川| 富顺县| 万州区| 高邮市| 门源| 益阳市| 福州市| 长海县| 麟游县| 崇阳县| 宝坻区| 潜江市| 镇康县| 东港市| 江川县| 定兴县| 电白县| 苏州市| 达日县| 七台河市| 宾阳县| 手游| 潍坊市| 米易县| 思茅市| 洛扎县| 晋中市| 鞍山市| 大连市| 绥棱县| 普兰店市| 河池市|